课题基金 / 基金详情

Relationship between p27^<Kip1> expression and tumor differention and prognosis in human oral squamous cell carcinoma.

Relationship between p27^<Kip1> expression and tumor differention and prognosis in human oral squamous cell carcinoma.
人口腔鳞癌p27^<Kip1>表达与肿瘤分化及预后的关系。
批准号:
11671990
负责人:
HARADA Koji
金额:
$0.45万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

HARADA Koji的其他基金

相似基金

相关文献

中文摘要
翻译
我们利用免疫组织化学方法研究了p27^<Kip1>在口腔鳞状细胞癌(OSCCs)中的表达,并试图探讨各表达水平与肿瘤分级、T、N、分期、疗效和转归等临床病理特征之间的关系。高水平表达p27^<Kip1>与高分化病例(p<0.05)、NO病例(p<0.01)、非晚期病例(p<0.01)、良效病例(p<0.05)相关。p27^<Kip1>高表达组5年生存率为63.3%,显著高于p27^<Kip1>低表达组(45.5%)(p<0.05)。通过Cox比例风险模型,高水平表达p27^<Kip1>可显著降低死亡率。这些结果提示p27^<Kip1>蛋白表达可能与肿瘤分级、转移抑制、疗效和预后密切相关,是一种有用的预后指标。接下来,我们用pcDNA3.1 (stratagene)构建了p27^<Kip1>表达载体。并将其以正义或反义定向转染到OSCC细胞系(B88)中,试图调控B88细胞中的p27^<Kip1>基因。B88细胞过表达p27^<Kip1> (B88/Tp27sense)可抑制B88细胞的生长、侵袭和转移。相反,B88细胞中p27^<Kip1> (B88/ tp27反义)的低表达促进了B88细胞的生长、侵袭和转移。在肿瘤分化方面,我们可以检测到B88/ tp27反义细胞从鳞状细胞型到spindol细胞型的形态学变化,但HE染色未检测到亲本B88和B88/ tp27的差异。此外,我们可以通过免疫组化检测B88/ tp27感中天合蛋白和角蛋白7,8 (Cam 5.2)的诱导作用。提示p27^<Kip1>可能与OSSC终末分化有关。
英文摘要
We have investigated the expression of p27^<Kip1> in oral squamous cell carcinomas (OSCCs) using immunohistochemistry and have tried to investigate the relationship between each expression level and clinico-pathological characteristics such as tumor grade, T, N, stage classifications, effect and outcome. High levels of p27^<Kip1> expression were significantly related to well differentiated cases(p<0.05), NO cases (p<0.01), non advanced cases (p<0.01), and good effective cases (p<0.05). Five-year survival rate of p27^<Kip1> high expression cases was 63.3%, and it was significantly high than that of p27^<Kip1> low expression cases (45.5%) (p<0.05). By Cox's proportional hazards model, high levels of p27^<Kip1> expression significantly made the rate of death decrease. These results suggested that p27^<Kip1> protein expression may be closely related to tumor grade, inhibition of metastasis, effect and outcome, and an useful prognostic marker. Next, we have constructed p27^<Kip1> expression vectors with pcDNA3.1 (stratagene). Moreover, we transfected them to OSCC cell line (B88) in sense or anti-sense oriented, and tried to regulate the p27^<Kip1> gene in B88 cells. Overexpression of p27^<Kip1> in B88 cells (B88/Tp27sense) inhibited the growth, invasion and metastasis of them. Contradictory, low expression of p27^<Kip1> in B88 cells (B88/Tp27anti-sense) promoted the growth, invasion and metastasis. On tumor differentiation, we could detect the morphological change from squamous cell type to spindol cell type in B88/Tp27anti-sense though we could not detect the difference between parental B88 and B88/Tp27sense by HE staining. Moreover, we could detect the induction of involucrin and keratin 7,8 (Cam 5.2) in B88/Tp27sense immunohistochemically. These results suggested that p27^<Kip1> might be related to terminal differentiation of OSSC.
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
Carlile J: "VEGF expression in oral tissues, Possible relevance to angiogenesis, tumour progression and field cancerisation."J Oral Pathol Med. (in press).
Carlile J:“口腔组织中的 VEGF 表达,可能与血管生成、肿瘤进展和局部癌化相关。”J Oral Pathol Med。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Harada K, Lu S, Chisholm MD, Syrjnen S and Schor AM: "Angiogenesis and vasodilation in skin warts. Association with HPV infection."Anticancer Res. 20. 4519-4524 (2000)
Harada K、Lu S、Chisholm MD、Syrjnen S 和 Schor AM:“皮肤疣中的血管生成和血管舒张。与 HPV 感染的关联。”抗癌研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Motegi K: "Effect of a mutant form of 1kB-α on 5-fluorouracil-induced apoptosis in transformed human salivary gland cells."Oral Oncol, Eur J Cancer. 37. 185-192 (2001)
Motegi K:“1kB-α 突变体对转化人唾液腺细胞中 5-氟尿嘧啶诱导的细胞凋亡的影响。”Oral Oncol,Eur J Cancer 37. 185-192 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Harada K and Ogden GR: "An overview of the cell cycle arrest protein p21^<WAF1>"Oral Oncol, Eur J Cancer. 36. 3-7 (2000)
Harada K 和 Ogden GR:“细胞周期阻滞蛋白 p21^<WAF1> 的概述”Oral Oncol,Eur J Cancer。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 18 条
    Development of novel treatment against refractory oral cancer by uptake inhibition of iron or induction of ferroptosis
    • 批准号:
      18K09814
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2018
    • 负责人:
      HARADA Koji
    • 依托单位:
    Development of new oral cancer treatments focused on mTOR inhibition leading to the anti-aging prevention and the healthy life-span extension
    • 批准号:
      15K11292
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2015
    • 负责人:
      HARADA Koji
    • 依托单位:
    Development of a novel functional preservation therapy against advanced, recurrent or unresectable oral cancers.
    • 批准号:
      24593034
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      HARADA Koji
    • 依托单位:
    Examination of the physical pictures of the field theories with nonlinearly realized symmetries by the Wilsonian renormalization group method
    • 批准号:
      22540286
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.83万
    • 财政年份:
      2010
    • 负责人:
      HARADA Koji
    • 依托单位:
    海外基金